Cart
sales@molnova.com
Lofemizole
CAS No. 65571-68-8
Lofemizole( —— )
Catalog No. M28418 CAS No. 65571-68-8
Lofemizole is an antagonist of CYP1A2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 55 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 97 | In Stock |
|
| 25MG | 164 | In Stock |
|
| 50MG | 241 | In Stock |
|
| 100MG | 342 | In Stock |
|
| 200MG | 471 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLofemizole
-
NoteResearch use only, not for human use.
-
Brief DescriptionLofemizole is an antagonist of CYP1A2.
-
DescriptionLofemizole is an antagonist of CYP1A2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorSIRT2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65571-68-8
-
Formula Weight192.65
-
Molecular FormulaC10H9ClN2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1[nH]cnc1-c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Rhodionin
Rhodionin and rhodionin can inhibit cytochrome P450 2D6 non-competitively with high specificity which could have implications for interactions with co-administered drugs; they can significantly suppress the elevation of the postprandial blood triglyceride level suggests that they may be to the treatment of lifestyle-related diseases such as hyperlipidemia and exogeneous obesity and to health foods.
-
CYP4A11/CYP4F2-IN-1
CYP4A11/CYP4F2-IN-1 is a cytochrome P450 (CYP) 4A11 and CYP4F2 inhibitor, applicable for research on kidney, cardiovascular, and cerebrovascular diseases.
-
Ginsenoside Rb3
Ginsenoside Rb3 is a natural triterpenoid saponin, exhibiting inhibition effect on TNFα-induced NF-κB transcriptional activity. It also inhibits the induction of COX-2 and iNOS mRNA.
